Crawford Investment Counsel Inc Astrazeneca PLC Transaction History
Crawford Investment Counsel Inc
- $5.34 Billion
- Q4 2024
A detailed history of Crawford Investment Counsel Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Crawford Investment Counsel Inc holds 1,614,566 shares of AZN stock, worth $126 Million. This represents 1.98% of its overall portfolio holdings.
Number of Shares
1,614,566
Previous 1,536,033
5.11%
Holding current value
$126 Million
Previous $120 Million
11.61%
% of portfolio
1.98%
Previous 2.1%
Shares
30 transactions
Others Institutions Holding AZN
# of Institutions
1,365Shares Held
512MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.71 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.2 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.92 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.89 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.87 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $242B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...